Rapamycin

Synonyms: 雷帕霉素; 西罗莫司; Sirolimus; AY-22989; NSC 226080
Rapamycin (Sirolimus) 是一种有效、特异性且具有血脑屏障透过性的 mTOR 抑制剂,作用于 HEK293 细胞时抑制 mTOR 的 IC50 为 0.1 nM,作为一种分子胶 (molecular glue),它能够将 FKBP12 和 mTOR 蛋白结合在一起,从而抑制 mTOR 激酶的活性,同时与 FKBP12 结合并抑制 mTORC1,此外还是一种自噬 (autophagy) 激活剂和免疫抑制剂。
产品编号: MS-T42882 纯度: 99.79% CAS No.: 53123-88-9 分子式: C51H79NO13 分子量: 914.17
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
10mM * 1mL in DMSO
询价
3-5 天
5mg
询价
3-5 天
10mg
询价
3-5 天
25mg
询价
3-5 天
50mg
询价
3-5 天
100mg
询价
3-5 天
500mg
询价
3-5 天
1g
询价
3-5 天
5g
询价
询价
10g
询价
询价

产品描述

Rapamycin (Sirolimus) 是一种有效、特异性且具有血脑屏障透过性的 mTOR 抑制剂,作用于 HEK293 细胞时抑制 mTOR 的 IC50 为 0.1 nM,作为一种分子胶 (molecular glue),它能够将 FKBP12 和 mTOR 蛋白结合在一起,从而抑制 mTOR 激酶的活性,同时与 FKBP12 结合并抑制 mTORC1,此外还是一种自噬 (autophagy) 激活剂和免疫抑制剂。

生物实验数据

生物活性

Rapamycin (Sirolimus) is a potent, specific, blood-brain barrier-penetrant mTOR inhibitor with an IC50 of 0.1 nM for mTOR inhibition in HEK293 cells; as a molecular glue, it brings FKBP12 and mTOR proteins together to inhibit mTOR kinase activity, binds FKBP12 and inhibits mTORC1, and also acts as an autophagy activator and immunosuppressant.

IC50 & Target mTOR:0.1 nM (HEK293 cells), MCF-7 cells:18.74 μM, HEK293 cells:0.1 nM, MDA-MB-468 cells:37.2 μM, A549 cells:18.74 μM, MDA-MB-231 cells:> 10000 nM, HEK293T cells:0.1 nM (EC50), HeLa cells:> 10000 nM, MEF cells:0.05 nM
体外研究
(In Vitro)

Rapamycin (12.5-100 nM;24 小时) 处理在所有测试的细胞系 (A549、SPC-A-1、95D 和 NCI-H446 细胞) 中以剂量依赖性方式对肺癌细胞增殖产生适度抑制作用,达到约 100 nM 时细胞增殖减少 30-40%,而 12.5 nM 时减少约 10%。
将肺癌细胞系 95D 细胞单独或联合暴露于 Rapamycin (10 nM、20 nM) 和 RP-56976 (1 nM、10 nM) (Rapamycin 20 nM + RP-56976 10 nM)。单独暴露于 Rapamycin 或 RP-56976 24 小时后,不会显着改变 ERK1/2 的表达或磷酸化水平,而 Rapamycin 与 RP-56976 联合处理的细胞表现出 ERK1/2 磷酸化水平的显着降低。

Cell Viability Assay

Cell Line: Lung cancer cell lines A549, SPC-A-1, 95D and NCI-H446
Concentration: 12.5 nM, 25 nM, 50 nM, 100 nM
Incubation Time: 24 hours
Result: Treatment exerted modest inhibitory effect on lung cancer cell proliferation in a dose-dependent manner in all cell lines.

Western Blot Analysis

Cell Line: 95D cells
Concentration: 10 nM and 20 nM
Incubation Time: 24 hours
Result: Combination treatment with RP-56976 decreased phosphorylation of ERK.
体内研究
(In Vivo)

Rapamycin (2.0 mg/kg;腹腔内注射;每隔一天;28 天) 单独使用有中等的抑制作用。然而,与对照组、Rapamycin 组相比,Metformin (MS-K91034) 联合 Rapamycin 对肿瘤生长的抑制作用明显增强。

Animal Model: 24 male nu/nu mice aged 4-5 week old (15-20 g)
Dosage: 2.0 mg/kg
Administration: Intraperitoneal injection; every other day; 28 days
Result: Had a moderate inhibitory effect in monotherapy group. The combination with Metformin exerted a significantly increased inhibition of tumor growth.
Clinical Trial
NCT Number Sponsor Condition Start Date Phase
NCT00375245 University of Chicago

Tumors|Neoplasm Metastasis

2006-09 PHASE1
NCT00047073 Jonsson Comprehensive Cancer Center

Brain and Central Nervous System Tumors

2002-07 PHASE1|PHASE2
NCT00126672 Dana-Farber Cancer Institute|National Cancer Institute (NCI)|Wyeth is now a wholly owned subsidiary of Pfizer|Tuberous Sclerosis Alliance

Nonmalignant Neoplasm|Tuberous Sclerosis|Lymphangioleimyomatosis|Kidney Angiomyolipoma

2005-12-20 PHASE2
NCT04488601 AgelessRx|University of California, Los Angeles

Aging

2020-01-01 PHASE2
NCT05190627 Institut d´Investigació Biomèdica de Bellvitge

Lymphangioleiomyomatosis

2021-11-01 PHASE2
NCT06743503 Nanjing IASO Biotechnology Co., Ltd.|The First Affiliated Hospital with Nanjing Medical University

Large B-cell Lymphoma

2025-04-11 PHASE1
NCT01255956 Medical University of Warsaw|KCRI

In-Stent Restenosis

2010-12 PHASE3
NCT01684449 Grupo Espanol de Investigacion en Sarcomas

Advanced Soft Tissue Sarcoma

2010-01 PHASE1|PHASE2
NCT00457808 Children´s Hospital Medical Center, Cincinnati|The LAM Foundation|Tuberous Sclerosis Alliance

Tuberous Sclerosis|Lymphangioleiomyomatosis

2002-12 PHASE2
NCT00402415 Yale University|Pfizer

Tumors

2006-02 PHASE1
NCT00304954 National Eye Institute (NEI)

Age-Related Macular Degeneration|Choroidal Neovascularization

2006-02 PHASE2
NCT01678937 Northwestern University|Northwestern Memorial Hospital

Liver Transplant Rejection|Immunosuppression

2007-09  
NCT06029569 Shanghai Bomaian Medical Technology Co., Ltd

Peripheral Arterial Disease

2023-09-15 NA
NCT05342519 Medical University of South Carolina|American Skin Association

Vitiligo

2022-07-28 PHASE2
NCT01014234 Fondazione IRCCS Policlinico San Matteo di Pavia

Kidney Transplantation

2008-07 PHASE2
NCT06653842 Palvella Therapeutics, Inc.

Cutaneous Venous Malformations

2024-12-20 PHASE2
NCT00533442 University of Miami|Astellas Pharma Inc

Type 1 Diabetes

2000-09 PHASE2
NCT00707135 University of Chicago|National Institutes of Health (NIH)

Advanced Cancer

2005-06 PHASE1
NCT00276744 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI)

Pancreatic Cancer

2005-10 PHASE2
NCT06658093 The University of Texas Health Science Center at San Antonio|National Institute on Aging (NIA)

Aging

2025-08-13 EARLY_PHASE1
NCT00401115 Santen Inc.|MacuSight, Inc.

Diabetic Macular Edema|Diabetic Retinopathy

2006-09 PHASE1
NCT07570433 Oriol Manuel|Centre Hospitalier Universitaire Bordeaux|Centre Hospitalier Universitaire de Toulouse, FRANCE|Hospital Vall d´Hebron

CMV Infection

2026-04 PHASE4
NCT02596828 University of Regensburg

Pineoblastoma

2016-04 PHASE2
NCT02675153 The Second Hospital of Nanjing Medical University

Crohn´s Diseases

2015-04-01 NA
NCT00830466 University of California, Irvine|Beckman Laser Institute University of California Irvine|Pfizer

Port Wine Stain

2008-12 PHASE1
NCT04482712 The University of Texas Health Science Center at San Antonio|The Claude D. Pepper Older Americans Independence Centers

Acute Lung Injury+Acute Respiratory Distress Syndrome (ARDS)|Respiratory Failure|Sars-CoV2

2021-04 PHASE1|PHASE2
NCT07436611 AFT Pharmaceuticals, Ltd.

Port Wine Stains

2026-04 PHASE2
NCT07354620 The Christ Hospital

Aging

2025-02-15 EARLY_PHASE1
NCT02080624 Clinica Universidad de Navarra, Universidad de Navarra

Sturge- Weber Syndrome

2011-01 PHASE2
NCT01054313 M.D. Anderson Cancer Center

Advanced Cancer

2010-01 PHASE1
NCT04608448 The University of Texas Health Science Center at San Antonio|National Institute on Aging (NIA)

Aging|Epigenetics|Inflammatory Mediators

2021-04-28 EARLY_PHASE1
NCT02688842 Shanghai MicroPort Medical (Group) Co., Ltd.

Coronary Heart Disease

2014-05 NA
NCT00874562 Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Boston Children´s Hospital|National Cancer Institute (NCI)

Acute Lymphoblastic Leukemia

2007-07 PHASE1
NCT07092618 AgelessRx

Longevity|GLP-1|Geroscience|Aging

2024-12-17 PHASE2|PHASE3
NCT03359538 Azienda Ospedaliero-Universitaria di Modena|University of Modena and Reggio Emilia|Azienda Ospedaliero Universitaria Maggiore della Carita|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|University of Turin, Italy|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta|Azienda Ospedaliera Niguarda Cà Granda|Fondazione Salvatore Maugeri|University of Padova

Amyotrophic Lateral Sclerosis

2017-09-19 PHASE2
NCT00241189 University of California, Los Angeles

Systemic Sclerosis

2002-08 PHASE1|PHASE2
NCT06550271 AgelessRx

Aging

2023-04-25  
NCT03243019 University Hospital, Lille|Ministry of Health, France

Lymphatic Malformation|Pediatric

2018-06-25 PHASE2
NCT00708591 University of Chicago

Advanced Cancer

2004-10 PHASE1
NCT01467986 University of Regensburg

Neuroblastoma Recurrent

2013-08 PHASE2
NCT06308445 University Hospital, Toulouse

Familial Adenomatous Polyposis

2026-09-01 PHASE2
NCT05233722 University of Copenhagen|Danish Diabetes Academy

Insulin Sensitivity

2022-02-10 NA
NCT05532072 First Affiliated Hospital Xi´an Jiaotong University|Beijing Tongren Hospital|Cheloo Hospital (Qingdao), Shandong University|Jiangsu Province Hospital with Integration of Chinese and Western Medicine|Nanjing First Hospital, Nanjing Medical University|Zhejiang Provincial People´s Hospital|Southern Medical University, China|People´s Hospital of Xinjiang Uygur Autonomous Region|The Second Affiliated Hospital of Air Force Military Medical University

Graves Ophthalmopathy

2022-09 EARLY_PHASE1
NCT00583063 University of Chicago|Pfizer

Solid Tumors

2007-10 EARLY_PHASE1
NCT00223678 Vanderbilt University Medical Center

Kidney Transplant

2000-06 PHASE4
NCT07475546 AgelessRx

Healthspan Improvement|Aging|Longevity

2025-07-23 PHASE3
NCT05180708 Palvella Therapeutics, Inc.

Pachyonychia Congenita

2021-11-29 PHASE3
NCT02688829 Shanghai MicroPort Medical (Group) Co., Ltd.

Coronary Heart Disease

2009-12 NA
NCT05605665 Peking University People´s Hospital

Sj?gren´s Syndrome

2022-12-05 PHASE1|PHASE2
NCT05144698 Rapa Therapeutics LLC

Solid Tumor|Small Cell and Non-small Cell Lung Cancer|Head and Neck Cancer|Squamous Cell Carcinoma of Oral Cavity|Squamous Cell Carcinoma of Larynx|Squamous Cell Carcinoma of Nasopharynx|Squamous Cell Carcinoma of Other Specified Sites of Skin|Malignant Melanoma|Esophageal Squamous Cell Carcinoma

2021-08-01 PHASE1|PHASE2
NCT02646319 Mayo Clinic|National Cancer Institute (NCI)

Advanced Malignant Neoplasm|Cervical Squamous Cell Carcinoma|Endometrial Carcinoma|Malignant Uterine Neoplasm|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Head and Neck Carcinoma|Recurrent Malignant Neoplasm|Recurrent Ovarian Carcinoma|Recurrent Prostate Carcinoma|Recurrent Renal Cell Carcinoma|Solid Neoplasm|Stage III Bladder Cancer|Stage III Prostate Cancer|Stage III Renal Cell Cancer|Stage IIIA Breast Cancer|Stage IIIA Cervical Cancer|Stage IIIA Ovarian Cancer|Stage IIIB Breast Cancer|Stage IIIB Cervical Cancer|Stage IIIB Ovarian Cancer|Stage IIIC Breast Cancer|Stage IIIC Ovarian Cancer|Stage IV Breast Cancer|Stage IV Ovarian Cancer|Stage IV Prostate Cancer|Stage IV Renal Cell Cancer|Stage IVA Bladder Cancer|Stage IVA Cervical Cancer|Stage IVB Bladder Cancer|Stage IVB Cervical Cancer

2016-01 EARLY_PHASE1
NCT02481453 Institut National de la Santé Et de la Recherche Médicale, France

Inclusion Body Myositis (IBM)

2015-07-15 PHASE2|PHASE3
NCT01672151 First Affiliated Hospital of Suzhou Medical College

Immune Thrombocytopenic Purpura

2011-11  
NCT02048384 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Stand Up To Cancer

Metastatic Pancreatic Adenocarcinoma

2014-06-10 PHASE1
NCT00779194 State University of New York - Upstate Medical University|Pfizer

Systemic Lupus Erythematosus (SLE)

2008-10 PHASE2
NCT00780104 Abramson Cancer Center at Penn Medicine

Myeloid Leukemias|AML|Leukemia|CML

2007-07 PHASE1
NCT00908466 Johns Hopkins University|MacuSight, Inc.

Uveitis|Intermediate Uveitis|Posterior Uveitis|Panuveitis

2009-07 PHASE1
NCT01526356 The University of Texas Health Science Center, Houston

Angiofibromas|Tuberous Sclerosis

2012-05 PHASE2
NCT00803010 H. Lee Moffitt Cancer Center and Research Institute

Acute Graft Versus Host Disease

2008-09 PHASE2
NCT03383380 Children´s Hospital of Fudan University

Activated PI3K-delta Syndrome|Immunodeficiency Primary

2017-12-01 PHASE1|PHASE2
NCT06257420 Simmaron Research Inc.|Center For Complex Diseases-Seattle, WA|Sierra Internal Medicine, Incline Village, NV|Center for Complex Diseases- Palo Alto, CA|Simmaron Research Inc. R&D Lab, University of Wisconsin, Milwaukee (UWM)|Bateman Horne Center, Salt Lake City, UT|Mayo Clinic

Myalgic Encephalomyelitis|Long-COVID

2023-12-11  
NCT00891696 The University of Texas Medical Branch, Galveston|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Sarcopenia

2009-04 PHASE1
NCT04742777 The University of Texas Health Science Center at San Antonio|The Claude D. Pepper Older Americans Independence Centers|National Institute on Aging (NIA)

Aging

2022-02-01 PHASE2
NCT02803892 Piemonti Lorenzo|Italian Diabetes Foundation

Diabetes Mellitus, Type 1

2016-05 PHASE2
NCT00311623 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI)

Prostate Cancer

2006-08 PHASE1|PHASE2
NCT01183247 University Hospital, Basel, Switzerland|Novartis

Comparative Study|Immunosuppressive Agents

2008-07 PHASE4
NCT00123331 Heidelberg University|Wyeth is now a wholly owned subsidiary of Pfizer

Heart Transplantation|Renal Failure

2003-10 PHASE4
NCT00235560 University Hospital, Toulouse|French Innovative Leukemia Organisation

Acute Myeloid Leukemia

2005-06 PHASE2
NCT03767660 Peking Union Medical College Hospital|Air Force General Hospital of the PLA|Chinese Academy of Medical Sciences

Blue Rubber Bleb Nevus Syndrome|Venous Malformation

2018-07-31 PHASE4
NCT07058974 Icahn School of Medicine at Mount Sinai

Smokers|Former Smokers

2025-08-25 PHASE1
NCT01282697 University Hospital, Strasbourg, France|Gustave Roussy, Cancer Campus, Grand Paris

Refractory Solid Tumors in Children

2011-04-22 PHASE1
NCT03500367 Peking Union Medical College Hospital

Uterine Fibroids

2018-01-01 PHASE4
NCT03781050 Peking Union Medical College Hospital|Air Force General Hospital of the PLA|Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Peutz-Jeghers Syndrome

2018-09-16 PHASE4
NCT06683118 MicroPort NeuroTech Co., Ltd.

Cerebral Atherosclerotic Stenosis

2024-05-27 NA
NCT00306397 University Hospital, Basel, Switzerland

Kidney Transplantation

2005-01 PHASE4
NCT03298958 The University of Texas Health Science Center at San Antonio

Bladder Cancer

2018-11-01 PHASE3
NCT01396200 Abramson Cancer Center at Penn Medicine

Myeloma

2011-06 EARLY_PHASE1
NCT00467194 National Cancer Centre, Singapore

Liver Cancer

2006-12 PHASE1
NCT01649960 Mayo Clinic

Aging|CAD

2012-08 PHASE1
NCT06239480 Palvella Therapeutics, Inc.|FDA Office of Orphan Products Development

Microcystic Lymphatic Malformation

2024-07-31 PHASE3
NCT03732248 Medical University of South Carolina

Alcohol Use Disorder|Alcohol Dependence

2018-07-12 PHASE1
NCT00133887 Hospices Civils de Lyon

Skin Cancer|Kidney Transplantation

2004-04 PHASE3
NCT03826628 Dermatology Specialties Limited Partnership

Facial Angiofibroma|Tuberous Sclerosis

2019-07-28 PHASE2|PHASE3
NCT03161340 Mehdi Yousefi

Recurrent Implantation Failure

2017-07-11 PHASE2
NCT00598533 Deutsches Herzzentrum Muenchen

Coronary Heart Disease

2008-02 PHASE4
NCT00411788 Yale University|Genentech, Inc.

Breast Cancer

2006-12 PHASE2
NCT03140449 National Taiwan University Hospital

Facial Angiofibroma

2013-09-05 PHASE3
NCT06563817 Beijing Tiantan Hospital

Communicating Hydrocephalus|Cerebral Intraventricular Hemorrhage|Secondary Normal Pressure Hydrocephalus|Post Hemorrhagic Hydrocephalus

2024-08 PHASE2
NCT05836025 Columbia University

Perimenopausal

2023-06-01 PHASE2
NCT03112603 Incyte Corporation

Graft-versus-host Disease (GVHD)

2017-06-29 PHASE3
NCT00290069 Sociedad Andaluza de Trasplantes de Organos y Tejidos

Kidney Diseases|Graft Rejection

  PHASE4
NCT01903473 University of Liege

Chronic Graft-Versus-Host Disease|Acute Graft-Versus-Host Disease|Steroid Refractory Graft-Versus-Host Disease

2013-07 PHASE2
NCT01449955 University of Texas Southwestern Medical Center|North Texas Veterans Healthcare System

Posttraumatic Stress Disorder

2008-08 NA
NCT00901849 Roger Packer|Children´s National Research Institute

Low-grade Gliomas

2007-05 PHASE1
NCT00800722 University of California, Irvine|Pfizer|Beckman Laser Institute University of California Irvine

Port Wine Stain

2008-11 PHASE1
NCT02844270 Shanghai Bio-heart Biological Technology Co., Ltd.

Heart Diseases

2016-08-09 NA
NCT01060605 IRCCS San Raffaele|Ministry of Education, Universities and Research, Italy|Juvenile Diabetes Research Foundation|Telethon-JDRF Center for Beta cell replacement: clinical core.

Diabetes Mellitus, Type 1

2001-10 PHASE3
NCT00286156 The Cleveland Clinic|Wyeth is now a wholly owned subsidiary of Pfizer

Polycystic Kidney Diseases

2006-10 PHASE1|PHASE2
NCT01853423 Le Bonheur Children´s Hospital|Pfizer|University of Tennessee

Facial Angiofibroma

2013-10 PHASE1
NCT00922129 St. Joseph´s Healthcare Hamilton

Prostate Cancer

2009-09 PHASE2|PHASE3
NCT00896012 University at Buffalo|Novartis|University of Washington

Kidney Transplantation

2008-01 PHASE4
NCT00195481 Wyeth is now a wholly owned subsidiary of Pfizer

Kidney Failure|Graft vs Host Disease

2004-04 PHASE4
NCT07033858 Shahid Beheshti University of Medical Sciences

Kidney Transplant; Complications

2025-03-01 NA
NCT04200911 The University of Texas Health Science Center at San Antonio|National Center for Advancing Translational Sciences (NCATS)

Cognitive Impairment, Mild|Alzheimer Disease

2020-06-01 EARLY_PHASE1
NCT00252655 Wayne State University

Kidney Transplantation

2004-01 PHASE4
NCT03214354 University of Calgary

Sickle Cell Disease|Stem Cell Transplant Complications|Red Blood Cell Disorder|Pure Red Cell Aplasia

2017-07-05 PHASE2
NCT00092222 National Cancer Institute (NCI)

Lymphoproliferative Disorder|HHV-8|Malignancy|HIV

2004-10-28 PHASE2
NCT01061853 University Hospital, Tours|Institut National de la Santé Et de la Recherche Médicale, France

Oral Lichen Planus

2008-02 PHASE3
NCT06160739 Sohag University

Microcystic Lymphatic Malformation|Combined Vascular Malformation|Vascular Malformations

2023-11-20  
NCT04959175 National Cancer Institute (NCI)

Hematologic Neoplasms

2021-09-23 PHASE1|PHASE2
NCT03121001 University of Illinois at Chicago

Sickle Cell Disease

2017-03-20 PHASE2
NCT05625919 CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)

2022-11-08 PHASE1|PHASE2
NCT04736953 State University of New York - Upstate Medical University

Lupus Erythematosus, Systemic

2025-01-01 PHASE2
NCT01462006 University of Virginia|National Heart, Lung, and Blood Institute (NHLBI)

Idiopathic Pulmonary Fibrosis|Diffuse Parenchymal Lung Disease|Interstitial Lung Disease

2011-10 NA
NCT01106833 Medical College of Wisconsin|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI)|Blood and Marrow Transplant Clinical Trials Network|National Marrow Donor Program

Chronic GVHD

2010-04 PHASE2|PHASE3
NCT06959771 National Institute of Allergy and Infectious Diseases (NIAID)

CD40L-HyperIgM Syndrome

2025-07-16 PHASE1|PHASE2
NCT06287944 City of Hope Medical Center|National Cancer Institute (NCI)

Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Myelodysplastic Syndrome

2025-07-01 PHASE1
NCT04324411 Peking Union Medical College Hospital

Autoimmune Anemia

2020-04-01 PHASE2|PHASE3
NCT00195429 Wyeth is now a wholly owned subsidiary of Pfizer

Kidney Failure|Graft vs Host Disease

2005-08 PHASE4
NCT06876142 National Cancer Institute (NCI)

Multiple Myeloma|Relapsed and+or Refractory Multiple Myeloma (RRMM)

2026-05-13 PHASE1|PHASE2
NCT02960997 Stanford University

Epidermolysis Bullosa Simplex|Epidermolysis Bullosa Simplex Kobner|Weber-Cockayne Syndrome

2016-05 PHASE2
NCT02443818 Centre Hospitalier Universitaire Dijon

Segmental Overgrowth Disorders Due to PIK3CA

2015-05 PHASE2
NCT07162038 National Cancer Institute (NCI)

Hematologic Malignancies|Hematologic Neoplasms

2025-11-14 PHASE1
NCT03016715 Premier Specialists, Australia

Epidermolysis Bullosa Simplex|Epidermolysis Bullosa Simplex Kobner|Weber-Cockayne Syndrome

2016-05 PHASE2
NCT04408625 Prevail Therapeutics|Eli Lilly and Company

Frontotemporal Dementia

2020-11-09 PHASE1|PHASE2
NCT01318915 National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN)

Renal Transplant Recipients

2011-07-25 EARLY_PHASE1
NCT04598815 University of Pisa

Graves Ophthalmopathy

2023-06-01 PHASE2
NCT00321906 University of Chicago|Astellas Pharma Inc|Loyola University|University of Florida|University of Pennsylvania|Baylor College of Medicine|Ochsner Health System|Columbia University|University of Wisconsin, Madison

Delayed Graft Function|Acute Graft Rejection

2002-04 PHASE4
NCT02683291 Associa??o Médico Espírita de Botucatu

Disorder Related to Renal Transplantation|Cytomegalovirus Infections

2014-01 PHASE4
NCT01791088 University of Chicago|National Cancer Institute (NCI)

Unspecified Adult Solid Tumor, Protocol Specific|Unspecified Childhood Solid Tumor, Protocol Specific

2012-06-13 PHASE1
NCT04362293 St. Jude Children´s Research Hospital

Sickle Cell Disease

2020-04-30 PHASE2
NCT03605927 H. Lee Moffitt Cancer Center and Research Institute|Bristol-Myers Squibb

Graft-versus-host-disease|GVHD|GVHD, Acute

2019-02-15 PHASE1
NCT00076570 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Kidney Transplantation

2004-01 PHASE2
NCT02793544 Center for International Blood and Marrow Transplant Research|National Marrow Donor Program

Myelodysplastic Syndrome (MDS)|Chronic Lymphocytic Leukemia (CLL)|Chemotherapy-sensitive Lymphoma|Acute Lymphoblastic Leukemia (ALL)+T Lymphoblastic Lymphoma|Acute Myelogenous Leukemia (AML)|Acute Biphenotypic Leukemia (ABL)|Acute Undifferentiated Leukemia (AUL)

2016-12 PHASE2
NCT01120028 University of Oxford|National Health Service, United Kingdom|Pfizer|Novartis

Kidney Transplantation

2010-09 PHASE2|PHASE3
NCT03780192 Scitech Produtos Medicos SA

Bifurcation Lesion|Coronary Artery Disease

2019-02-28  
NCT00491517 Mario Negri Institute for Pharmacological Research

Polycystic Kidney

2007-03 PHASE2
NCT06075368 Genoss Co., Ltd.

Acute Coronary Syndrome|Percutaneous Coronary Intervention

2020-03-16  
NCT02126527 Mayo Clinic|National Cancer Institute (NCI)

Recurrent Non-small Cell Lung Cancer|Unspecified Adult Solid Tumor, Protocol Specific

2013-08 PHASE1
NCT02117596 Pediatric Nephrology of Alabama|Pfizer|The Emmes Company, LLC

Renal Transplant

2007-11 NA
NCT02722668 Masonic Cancer Center, University of Minnesota

Acute Leukemia|Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia+Lymphoma|Burkitt´s Lymphoma|Natural Killer Cell Malignancies|Chronic Myelogenous Leukemia|Myelodysplastic Syndrome|Large-cell Lymphoma|Hodgkin Lymphoma|Multiple Myeloma|Relapsed Chronic Lymphocytic Leukemia|Relapsed Small Lymphocytic Lymphoma|Marginal Zone B-cell Lymphoma|Follicular Lymphoma|Lymphoplasmacytic Lymphoma|Mantle-cell Lymphoma|Prolymphocytic Leukemia|Bone Marrow Failure Syndromes|Myeloproliferative Neoplasms+Myelofibrosis|Biphenotypic+Undifferentiated+Prolymphocytic Leukemias|MRD Positive Leukemia|Leukemia or MDS in Aplasia|Relapsed T-Cell Lymphoma|Relapsed Multiple Myeloma|Plasma Cell Leukemia

2017-05-15 PHASE2
NCT05327023 National Cancer Institute (NCI)

Hematologic Neoplasms

2022-05-23 PHASE1|PHASE2
NCT00426517 National Institute of Allergy and Infectious Diseases (NIAID)

Inherited Immune Deficiencies

2007-01-19 EARLY_PHASE1
NCT01754389 Dana-Farber Cancer Institute

Graft Versus Host Disease

2013-01 PHASE2
NCT02062944 Northwestern University

Acute Rejection of Liver Transplant|Effects of Immunosuppressant Therapy

2013-03 NA
NCT00317798 University of Rochester

Drug+Agent Toxicity by Tissue+Organ|Multiple Myeloma and Plasma Cell Neoplasm

2006-04 PHASE1
NCT00602693 Masonic Cancer Center, University of Minnesota

Leukemia|Lymphoma|Multiple Myeloma|Plasma Cell Neoplasm|Myelodysplastic Syndromes

2007-07-23 PHASE1
NCT04707209 The Hospital for Sick Children

Retinal Astrocytic Hamartoma

2020-11-04 NA
NCT02208791 University of Sao Paulo General Hospital

Kidney Transplantation

2014-07 PHASE4
NCT04511247 Concept Medical Inc.

Peripheral Artery Disease|Atherosclerosis|Arterial Disease of Legs

2020-08-15 NA
NCT00317785 Fred Hutchinson Cancer Center|National Cancer Institute (NCI)

Leukemia|Lymphoma|Myelodysplastic Syndromes

2005-05 PHASE2
NCT00792948 National Cancer Institute (NCI)

Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Adult L1 Acute Lymphoblastic Leukemia|Adult L2 Acute Lymphoblastic Leukemia|Adult T Acute Lymphoblastic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia

2009-09-01 PHASE2
NCT07165886 CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Gastroenteropancreatic Neuroendocrine Tumors

2025-08-29 PHASE2|PHASE3
NCT02995096 Rigshospitalet, Denmark

Liver Transplantation

2016-01  
NCT03253913 University of Cincinnati|National Heart, Lung, and Blood Institute (NHLBI)

Lymphangioleiomyomatosis

2018-03-31 PHASE2
NCT04582136 Chinese SLE Treatment And Research Group|Beijing Municipal Science & Technology Commission|North China Pharmaceutical Group Corporation

Systemic Lupus Erythematosus

2021-03-04 PHASE3
NCT05386914 University of Missouri-Columbia

Genetic Predisposition to Disease|Healthy Volunteers

2023-03-02 PHASE1
NCT00388362 Stanford University

Graft vs Host Disease

2005-11 PHASE2
NCT05719883 Beijing Tiantan Hospital|Alain Medical (Beijing) Co., Ltd.

Intracranial Arteriosclerosis|Stroke (CVA) or TIA

2023-02-20 NA
NCT01802268 Helio Tedesco Silva Junior|Pfizer

Kidney Transplant

2008-02 PHASE4
NCT03292861 Cedars-Sinai Medical Center|Genzyme, a Sanofi Company

Heart Transplantation

2018-09-13 PHASE2
NCT00999258 Temple University|Wyeth is now a wholly owned subsidiary of Pfizer

Glomerular Filtration Rate|Chronic Allograft Nephropathy

2009-09 PHASE4
NCT00305682 Masonic Cancer Center, University of Minnesota

Myeloproliferative Disorders|Leukemia|Lymphoma|Myelodysplastic Syndromes

2005-06 PHASE2
NCT00544115 City of Hope Medical Center|National Cancer Institute (NCI)

Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases|Precancerous+Nonmalignant Condition

2001-10-16 PHASE2
NCT04612179 IHF GmbH - Institut für Herzinfarktforschung

Coronary Disease

2021-06-23  
NCT01217125 Fundacio Puigvert|Ministry of Health, Spain

Angiomyolipoma

2008-10 PHASE4
NCT03660930 University of Washington|Aadi Bioscience, Inc.

Advanced Soft Tissue Sarcoma|Locally Advanced Soft Tissue Sarcoma|Metastatic Soft Tissue Sarcoma

2019-04-01 PHASE1|PHASE2
NCT04921722 Children´s Hospital of Fudan University

Kaposiform Hemangioendothelioma|Tufted Angioma|Superficial Vascular Anomalies|Superficial Lymphatic Malformations

2021-10-22 PHASE4
NCT01087554 M.D. Anderson Cancer Center

Advanced Cancer

2010-03 PHASE1
NCT00166829 National Taiwan University Hospital

Kidney Transplantation

2004-05 PHASE4
NCT00821080 Massachusetts General Hospital|Brigham and Women´s Hospital|Dana-Farber Cancer Institute|AstraZeneca

Glioblastoma

2008-10 PHASE1
NCT00934791 Mayo Clinic|Wyeth is now a wholly owned subsidiary of Pfizer

Polycystic Liver Disease

2009-02 NA
NCT00130546 University Hospital Freiburg|Cordis Medizinische Apparate GmbH

Coronary Artery Disease

2004-11 PHASE3
NCT02517918 Institut Bergonié|Reliable Cancer Therapies|Pfizer

Solid Tumor|Osteosarcoma

2015-02 PHASE1
NCT06271590 Concept Medical Inc.|Cardiovascular Research Foundation, New York

Coronary Artery Disease|Native Coronary Artery Stenosis|Cardiovascular Diseases

2025-05-20 NA
NCT01927120 H. Lee Moffitt Cancer Center and Research Institute

Graft-Versus-Host-Disease

2014-03-25 PHASE2
NCT00118742 Hoffmann-La Roche

Liver Transplantation

2005-08 PHASE4
NCT00346151 National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN)

Renal Transplant

2006-12 PHASE2
NCT00079183 Fred Hutchinson Cancer Center|National Cancer Institute (NCI)

Graft Versus Host Disease

2002-04 PHASE2
NCT02574728 Emory University|Cannonball Kids´ Cancer Foundation|Hyundai Hope On Wheels

Cancer

2015-06 PHASE2
NCT05556681 C. R. Bard

Peripheral Arterial Disease|Peripheral Artery Disease|Stenosis Artery

2022-08-02 NA
NCT07241936 CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Advanced Solid Tumors

2025-11-13 PHASE1|PHASE2
NCT04698512 Singapore General Hospital

Dialysis Access Malfunction|End Stage Renal Failure on Dialysis|End Stage Renal Disease|Fistulas Arteriovenous|Stenosis

2019-05-21  
NCT00023244 National Institute of Allergy and Infectious Diseases (NIAID)|Cooperative Clinical Trials in Pediatric Transplantation

End-Stage Renal Disease

2001-01 PHASE2
NCT00940381 M.D. Anderson Cancer Center

Advanced Cancer

2009-07 PHASE1
NCT01958190 Foundation for Liver Research

Liver Disease

2011-02-07 PHASE4
NCT02282904 National Institute of Allergy and Infectious Diseases (NIAID)

Chronic Granulomatous Disease

2014-10-23 PHASE1|PHASE2
NCT00374647 University of Cincinnati

Primary Renal Allograft

2005-03 PHASE4
NCT05458492 Assistance Publique - H?pitaux de Paris

Sarcoidosis|Cutaneous Sarcoidosis

2022-07 PHASE2
NCT02753309 The University of Texas Health Science Center at San Antonio

Bladder Cancer

2016-06 EARLY_PHASE1
NCT02583893 Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Recurrent Adult Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia

2015-10-07 PHASE2
NCT01331135 Emory University|Children´s Healthcare of Atlanta

Ewing´s Sarcoma|Osteosarcoma|Astrocytoma|Atypical Teratoid+Rhabdoid Tumor|Ependymoma|Germ Cell Tumor|Glioma|Medulloblastoma|Rhabdoid Tumor|Retinoblastoma|Clear Cell Sarcoma|Renal Cell Carcinoma|Wilms Tumor|Hepatoblastoma|Neuroblastoma|Rhabdomyosarcoma

2011-04 PHASE1
NCT00305396 Vanderbilt University|Genzyme, a Sanofi Company

Kidney Transplantation

2004-04 PHASE4
NCT00266123 Wyeth is now a wholly owned subsidiary of Pfizer

Graft Rejection|Kidney Failure|Kidney Transplant

2004-03 PHASE4
NCT00140543 EUROSPK Study Group|Fujisawa GmbH|Hoffmann-La Roche|Wyeth is now a wholly owned subsidiary of Pfizer|Neovii Biotech|Genzyme, a Sanofi Company

Diabetes Mellitus, Type 1|Diabetic Nephropathy

2002-02 PHASE3
NCT04236609 Concept Medical Inc.

Diabetes|Coronary Artery Disease|Acute Coronary Syndrome

2020-06-15 NA
NCT03150914 University of Cincinnati|National Heart, Lung, and Blood Institute (NHLBI)|National Center for Advancing Translational Sciences (NCATS)|The LAM Foundation

LAM|Lymphangioleiomyomatosis

2018-01-01 PHASE3
NCT00589563 City of Hope Medical Center|National Cancer Institute (NCI)

Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Infection|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms|Precancerous Condition|Secondary Myelofibrosis|Small Intestine Cancer

2007-05 PHASE2
NCT01049633 National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Type 1 Diabetes Mellitus

   
NCT02588339 H. Lee Moffitt Cancer Center and Research Institute|Novartis

Graft Versus Host Disease|GVHD

2016-03-04 PHASE2
NCT03047980 Anne Comi, MD|Children´s Hospital Medical Center, Cincinnati|Pfizer|National Institutes of Health (NIH)|Faneca 66 Foundation|National Institute of Neurological Disorders and Stroke (NINDS)

Sturge-Weber Syndrome

2017-01 PHASE2|PHASE3
NCT00144703 Dana-Farber Cancer Institute|Brigham and Women´s Hospital

Hematologic Malignancies|Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndrome|Non-Hodgkin´s Lymphoma|Hodgkin´s Disease

2002-07 PHASE2
NCT01536054 Roswell Park Cancer Institute|National Cancer Institute (NCI)|Sanofi Pasteur, a Sanofi Company

Recurrent Fallopian Tube Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Primary Peritoneal Cavity Cancer|Stage IIA Fallopian Tube Cancer|Stage IIA Ovarian Epithelial Cancer|Stage IIA Primary Peritoneal Cavity Cancer|Stage IIB Fallopian Tube Cancer|Stage IIB Ovarian Epithelial Cancer|Stage IIB Primary Peritoneal Cavity Cancer|Stage IIC Fallopian Tube Cancer|Stage IIC Ovarian Epithelial Cancer|Stage IIC Primary Peritoneal Cavity Cancer|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Epithelial Cancer|Stage IIIA Primary Peritoneal Cavity Cancer|Stage IIIB Fallopian Tube Cancer|Stage IIIB Ovarian Epithelial Cancer|Stage IIIB Primary Peritoneal Cavity Cancer|Stage IIIC Fallopian Tube Cancer|Stage IIIC Ovarian Epithelial Cancer|Stage IIIC Primary Peritoneal Cavity Cancer|Stage IV Fallopian Tube Cancer|Stage IV Ovarian Epithelial Cancer|Stage IV Primary Peritoneal Cavity Cancer

2012-08-20 PHASE1
NCT00233792 Cordis US Corp.

Coronary Artery Disease

1999-12 PHASE1|PHASE2
NCT06799195 University of Nebraska

Hematological Malignancies|Graft-versus-Host Disease (GVHD)

2025-06-23 PHASE2
NCT00509431 Jonsson Comprehensive Cancer Center

Brain and Central Nervous System Tumors

2006-08 PHASE1
NCT05663944 Nottingham University Hospitals NHS Trust

Advanced Chronic Liver Disease

2022-07-25 PHASE2
NCT04469530 Emory University|PeachBowl LegACy Fund

Solid Tumor

2020-09-16 PHASE2
NCT00634244 National Cancer Institute (NCI)

Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Recurrent Adult Acute Myeloid Leukemia

2008-10 PHASE2
NCT01684982 San Giuseppe Moscati Hospital

Acute Myocardial Infarction

2007-04 PHASE4
NCT00223054 University Hospital Schleswig-Holstein|University of Kiel

Function of Renal Transplant

2005-03  
NCT03500848 Southern Medical University, China|First Affiliated Hospital, Sun Yat-Sen University|Nanfang Hospital, Southern Medical University

Liver Transplantation

2018-05-01 PHASE2|PHASE3
NCT02042326 Centre Hospitalier Universitaire, Amiens

Arteriovenous Malformations

2014-09-12 PHASE2
NCT02917096 City of Hope Medical Center|National Cancer Institute (NCI)

Primary Myelofibrosis|Secondary Myelofibrosis

2016-11-13 PHASE1
NCT00670423 Jennifer E. Schwartz|Millennium Pharmaceuticals, Inc.

Graft vs Host Disease|Peripheral Blood Stem Cell Transplantation|Transplantation, Homologous

2008-05-16 PHASE1
NCT03662412 Second Affiliated Hospital, School of Medicine, Zhejiang University

Pancreatic Cancer

2018-06-01 PHASE1|PHASE2
NCT00693030 A.O. Ospedale Papa Giovanni XXIII|Case Western Reserve University|Medtronic Vascular|Boston Scientific Corporation

Coronary Artery Disease

2006-08 PHASE4
NCT05860881 Melanoma and Skin Cancer Trials Limited|Monash University|The University of Queensland

Solid Organ Transplant Recipients|Skin Cancer

2024-02-09 PHASE3
NCT07052929 Astellas Gene Therapies

X-Linked Myotubular Myopathy

2025-12-15 PHASE1|PHASE2
NCT02821507 Leiden University Medical Center

Conventional Chondrosarcoma|Myxoid Liposarcoma|Mesenchymal Chondrosarcoma|Dedifferentiated Chondrosarcoma

2014-06 PHASE2
NCT04370795 National Institute of Allergy and Infectious Diseases (NIAID)

Severe Combined Immune Deficiency (SCID)

2025-11-26 PHASE1|PHASE2
NCT01121744 Sahajanand Medical Technologies Limited

Coronary Artery Disease

2010-04 NA
NCT04348292 Emory University|National Cancer Institute (NCI)

Lung Non-Small Cell Carcinoma|Stage I Lung Cancer AJCC v8|Stage IA1 Lung Cancer AJCC v8|Stage IA2 Lung Cancer AJCC v8|Stage IA3 Lung Cancer AJCC v8|Stage IB Lung Cancer AJCC v8|Stage II Lung Cancer AJCC v8|Stage IIA Lung Cancer AJCC v8|Stage IIB Lung Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8

2021-01-22 PHASE1
NCT01134952 London Health Sciences Centre

Hepatitis C

2010-06 PHASE4
NCT07256249 Fundación EPIC

Cardiovascular Diseases

2025-12-11  
NCT06261060 M.D. Anderson Cancer Center

Familial Platelet Disorder|Hematopoietic

2024-06-20 PHASE2
NCT01499888 University of Illinois at Chicago

Sickle Cell Disease

2011-11-11 PHASE1|PHASE2
NCT02891603 H. Lee Moffitt Cancer Center and Research Institute|CTI BioPharma|National Heart, Lung, and Blood Institute (NHLBI)

Graft Vs Host Disease|GVHD

2017-06-08 PHASE1|PHASE2
NCT04172922 Nemours Children´s Clinic

Vascular Anomaly

2020-04-01 PHASE1
NCT02513303 Vascular Therapies, Inc.

Complication of Renal Dialysis|End Stage Renal Disease|End Stage Kidney Disease|ESRD|Chronic Kidney Failure|Complication of Hemodialysis|Vascular Access Complication|Arteriovenous Fistula

2015-11 PHASE3
NCT01027000 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|Genentech, Inc.|Biologics, Inc.

Leukemia|Lymphoma

2010-02 PHASE2
NCT04409691 Shanghai Children´s Medical Center

Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)

2020-07-01 PHASE1
NCT05436418 National Cancer Institute (NCI)

Peripheral Blood Stem Cell Transplantation|Hematopoietic Stem Cell Transplantation

2022-11-18 PHASE1|PHASE2
NCT03972592 University Hospital, Tours|University Hospital, Angers

Vascular Malformations|Lymphatic Malformation

2019-06-05 PHASE2
NCT04411654 Prevail Therapeutics|Eli Lilly and Company

Gaucher Disease, Type 2

2021-06-29 PHASE1|PHASE2
NCT00392951 Children´s Hospital of Philadelphia

Autoimmune Pancytopenia|Autoimmune Lymphoproliferative Syndrome (ALPS)|Evans Syndrome|Idiopathic Thrombocytopenic Purpura|Anemia, Hemolytic, Autoimmune|Autoimmune Neutropenia|Lupus Erythematosus, Systemic|Inflammatory Bowel Disease|Rheumatoid Arthritis

2006-12 PHASE1|PHASE2
NCT01309022 National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN)

Diabetes Mellitus, Type 1

   
NCT04896177 Shenzhen Salubris Pharmaceuticals Co., Ltd.

Coronary Bifurcation Lesions

2021-03-18 NA
NCT06727305 University of Texas Southwestern Medical Center|University of Maryland, Baltimore|National Institute on Aging (NIA)

Aging

2026-02 PHASE1|PHASE2
NCT03077542 National Heart, Lung, and Blood Institute (NHLBI)

Sickle Cell Disease

2017-04-06 PHASE1|PHASE2
NCT03468478 Hospital do Rim e Hipertens?o

Kidney Transplant Infection

2017-06-18 PHASE4
NCT00957320 Emory University

Acute Lymphoblastic Leukemia

2009-06 PHASE1
NCT01116232 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI)

Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Lymphoproliferative Disorder|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms

2010-08 PHASE2
NCT00434811 National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Type 1 Diabetes Mellitus

2006-10 PHASE3
NCT02440789 Advancing Clinical Therapeutics Globally for HIV+AIDS and Other Infections|National Institute of Allergy and Infectious Diseases (NIAID)

HIV-1 Infection

2015-12-21 PHASE1|PHASE2
NCT00811616 Sahajanand Medical Technologies Limited

Coronary Artery Disease

2006-07 NA
NCT00414648 University of Cincinnati|Office of Rare Diseases (ORD)|FDA Office of Orphan Products Development|National Center for Research Resources (NCRR)

Lymphangioleiomyomatosis

2006-12 PHASE3
NCT00368914 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI)

Unspecified Adult Solid Tumor, Protocol Specific

2004-12 PHASE1
NCT00038948 Wyeth is now a wholly owned subsidiary of Pfizer

Renal Transplantation

2002-01 PHASE3
NCT00656643 Santen Inc.|MacuSight, Inc.

Diabetic Macular Edema

2008-06 PHASE2
NCT02504307 Scitech Produtos Medicos SA

Coronary Artery Disease

2015-07 PHASE4
NCT00556933 University of Nebraska|Genzyme, a Sanofi Company

End-stage Renal Disease

2004-04-01 PHASE4
NCT07159087 Genoss Co., Ltd.|Synex Consulting Ltd

Coronary Arterial Disease (CAD)

2025-02-19 NA
NCT02732899 Maturi, Raj K., M.D., P.C.

Exudative Age Related Macular Degeneration

2016-04 PHASE2
NCT01379209 Regimmune Corporation

Graft Versus Host Disease

2011-09 PHASE1|PHASE2
NCT01184885 Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University|American Society of Clinical Oncology

Lymphoid Malignancies (New or Relapsed)|Acute Lymphoblastic Leukemia|Burkitt Lymphoma|Lymphoblastic Lymphoma|Mantle Cell Lymphoma|Adult T-cell Leukemia+Lymphoma

2010-07 EARLY_PHASE1
NCT01592253 Seoul St. Mary´s Hospital

Acute Rejection of Renal Transplant

2012-05 NA
NCT00146614 Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Beth Israel Deaconess Medical Center|Massachusetts General Hospital

Graft Versus Host Disease|Hematologic Malignancies

2002-07 PHASE2
NCT00518375 Wyeth is now a wholly owned subsidiary of Pfizer

Kidney Transplantation

2000-04 PHASE4
NCT01737502 Mayo Clinic|National Cancer Institute (NCI)

Extensive Stage Small Cell Lung Carcinoma|Lung Adenocarcinoma|Recurrent Non-Small Cell Lung Carcinoma|Recurrent Small Cell Lung Carcinoma|Squamous Cell Lung Carcinoma|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIB Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer

2014-05-14 PHASE1|PHASE2
NCT04161144 Medical University of South Carolina

Smoking Cessation|Smoking, Cigarette|Nicotine Dependence

2018-10-01 PHASE2
NCT03582878 Institute for Clinical and Experimental Medicine

Diabetes Mellitus, Type 1

2004-01-01 PHASE4
NCT02833506 Roswell Park Cancer Institute|National Cancer Institute (NCI)

Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Stage IIA Fallopian Tube Cancer|Stage IIA Ovarian Cancer|Stage IIB Fallopian Tube Cancer|Stage IIB Ovarian Cancer|Stage IIC Fallopian Tube Cancer|Stage IIC Ovarian Cancer|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Primary Peritoneal Cancer|Stage IIIB Fallopian Tube Cancer|Stage IIIB Ovarian Cancer|Stage IIIB Primary Peritoneal Cancer|Stage IIIC Fallopian Tube Cancer|Stage IIIC Ovarian Cancer|Stage IIIC Primary Peritoneal Cancer|Stage IV Fallopian Tube Cancer|Stage IV Ovarian Cancer|Stage IV Primary Peritoneal Cancer

2017-12-08 PHASE1
NCT00141804 University Hospital Muenster|Proverum GmbH|KKS Netzwerk|Fujisawa GmbH

Kidney Transplantation

2002-01 PHASE3
NCT04177004 City of Hope Medical Center|National Cancer Institute (NCI)

Allogeneic Hematopoietic Stem Cell Transplant Recipient|Hematopoietic and Lymphoid Cell Neoplasm

2021-04-30 PHASE1
NCT07542314 Sarepta Therapeutics, Inc.

Duchenne Muscular Dystrophy

2026-04-30 PHASE4
NCT04341675 University of Cincinnati

COVID-19

2020-04-24 PHASE2
NCT01265030 MaineHealth|Desmoid Tumor Research Foundation|Pfizer

Desmoid Tumor

2014-02 PHASE1|PHASE2
NCT00195273 Wyeth is now a wholly owned subsidiary of Pfizer

Graft vs Host Disease|Kidney Transplantation

2004-11 PHASE3
NCT00484094 Pfizer

Kidney Transplantation

2011-07  
NCT02112981 Meril Life Sciences Pvt. Ltd.

Coronary Artery Disease

2014-11-05 NA
NCT00014911 National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN)

Diabetes Mellitus, Insulin-Dependent

2001-04 PHASE2
NCT03456700 Mayo Clinic

Ovarian Serous Tumor|Recurrent Ovarian Carcinoma

2018-03-30 PHASE2
NCT02152007 TransDerm, Inc.|Pachyonychia Congenita Project

Pachyonychia Congenita

2014-01 PHASE1
NCT00095329 National Institute of Allergy and Infectious Diseases (NIAID)|Autoimmunity Centers of Excellence

Multiple Sclerosis (MS) - Relapsing-remitting

2003-05 PHASE1|PHASE2
NCT00353301 University of Colorado, Denver|Genentech, Inc.

Renal Cell Carcinoma

2006-07 PHASE2
NCT03765944 Nobelpharma

Bioequivalence Study

2018-12-05 PHASE1
NCT07378657 Ain Shams University

Orbital Lymphatic Malformation

2025-11-01 PHASE3
NCT01709136 University of Pittsburgh

Hypertension

2005-12 PHASE2|PHASE3
NCT04772300 Jena University Hospital|Concept Medical Inc.|Vascuscience|CoreLab Black Forest|Center for Clinical Studies Jena

Peripheral Artery Disease

2022-02-10 NA
NCT03040934 Shanghai MicroPort Medical (Group) Co., Ltd.

Drug-Eluting Stents|Percutaneous Coronary Intervention|Tomography, Optical Coherence

2017-11-10 NA
NCT00043979 National Cancer Institute (NCI)

Sarcoma

2002-09-19 PHASE2
NCT04511234 Concept Medical Inc.

Peripheral Artery Disease|Atherosclerosis|Arterial Disease

2020-09-08 NA
NCT01809860 Astellas Pharma Global Development, Inc.|Basilea Pharmaceutica International Ltd

Healthy Subjects|Pharmacokinetics of Isavuconazole|Pharmacokinetics of Sirolimus

2011-11 PHASE1
NCT06802055 Peking Union Medical College Hospital

Aplastic Anaemia

2025-01-25 PHASE2
NCT00275535 Mayo Clinic|Wyeth is now a wholly owned subsidiary of Pfizer|Genzyme, a Sanofi Company|Roche Pharma AG

Kidney Diseases

2001-04 PHASE4
NCT00489281 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI)

Sickle Cell Disease

2008-06-23 PHASE2
NCT00406393 Medical College of Wisconsin|National Heart, Lung, and Blood Institute (NHLBI)|Blood and Marrow Transplant Clinical Trials Network|National Cancer Institute (NCI)

Leukemia, Myelocytic, Acute|Leukemia, Lymphocytic, Acute|Leukemia, Myeloid, Chronic|Myelodysplastic Syndromes

2006-11 PHASE3
NCT00240214 Wyeth is now a wholly owned subsidiary of Pfizer

Renal Transplantation

2001-04  
NCT02686619 Hoffmann-La Roche

Renal Transplantation

2004-11 PHASE3
NCT04534257 Singapore General Hospital

Critical Lower Limb Ischemia|Peripheral Artery Disease

2020-09-09 NA
NCT05384756 City of Hope Medical Center|National Cancer Institute (NCI)

Sickle Cell Disease

2022-07-13 PHASE1
NCT01537107 Mayo Clinic

Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific

2012-03-05 PHASE1
NCT00188955 University of Manitoba|Wyeth is now a wholly owned subsidiary of Pfizer

Kidney Transplantation

2004-03 PHASE4
NCT00490789 Cardiff University|University of Nottingham|St Georges Hospital Medical School|Royal Sussex County Hospital|The Tuberous Sclerosis Association|Wyeth is now a wholly owned subsidiary of Pfizer

Tuberous Sclerosis|Lymphangioleiomyomatosis

2005-10 PHASE2
NCT04660240 Instituto Nacional de Cardiologia Ignacio Chavez

Diabetes Mellitus|Coronary Artery Disease|Acute Coronary Syndrome

2020-10-01 NA
NCT05746689 Peking University International Hospital

IgG4-related Disease

2023-03-01 NA
NCT06300268 Advanced MedTech Solutions Pvt. Ltd.

Coronary Artery Disease|De Novo Stenosis Lesion|Coronary Stent Implantation

2024-06 NA
NCT00352976 Masonic Cancer Center, University of Minnesota

Fanconi Anemia

2006-05-18 PHASE2|PHASE3
NCT07151157 Ruijin Hospital

Adult-Onset Still´s Disease

2025-08-30 NA
NCT01203722 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI)

Hematologic Malignancies

2010-09 PHASE1|PHASE2
NCT00023231 National Institute of Allergy and Infectious Diseases (NIAID)

End-Stage Renal Disease

2001-02 NA
NCT04561739 Xijing Hospital

De Novo Stenosis|Coronary Artery Disease

2021-02-01 NA
NCT02110069 Boston Children´s Hospital|Pfizer

Kaposiform Hemangioendothelioma (KHE)|Kasabach-Merritt Syndrome|Tufted Angioma

2017-06-14 PHASE2
NCT02123966 Dana-Farber Cancer Institute

Chronic Graft-versus-Host-Disease|Oral Mucosal Disease Due to Graft-versus-host Disease

2014-07 PHASE2
NCT05896839 National Cancer Institute (NCI)

Clinical Stage III Cutaneous Melanoma AJCC v8|Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8|Metastatic Basal Cell Carcinoma|Metastatic Carcinoma in the Skin|Metastatic Melanoma|Metastatic Merkel Cell Carcinoma|Metastatic Skin Squamous Cell Carcinoma|Unresectable Basal Cell Carcinoma|Unresectable Melanoma|Unresectable Merkel Cell Carcinoma|Unresectable Skin Squamous Cell Carcinoma

2024-07-24 PHASE1|PHASE2
NCT04083183 Fred Hutchinson Cancer Center|National Heart, Lung, and Blood Institute (NHLBI)

Non-Malignant Neoplasm

2020-06-16 PHASE1|PHASE2
NCT00693446 Nantes University Hospital

Pancreas Transplantation|Kidney Transplantation

2004-04 PHASE4
NCT01428973 University of Liege|AZ Sint-Jan AV|Ziekenhuis Netwerk Antwerpen (ZNA)|Jules Bordet Institute|University Hospital, Gasthuisberg|Universitair Ziekenhuis Brussel|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|University Hospital, Antwerp|Cliniques Universitaires de Mont-Godinne|Hospital de Jolimont|University Hospital, Ghent|AZ Delta

Graft-Versus-Host Disease|Hematological Malignancies

2011-09 PHASE2
NCT00789308 National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Clinical Islet Transplantation Consortium

Diabetes Mellitus, Type I

2008-07-11 PHASE2
NCT04371640 Walter K. Kraft

SARS-CoV-2|Covid-19

2020-07-06 PHASE1
NCT05908331 Concept Medical Inc.|Cardiovascular Research Foundation, New York

In-Stent Restenosis|Cardiovascular Diseases|Coronary Artery Disease

2024-04-16 NA
NCT06960928 Icahn School of Medicine at Mount Sinai|PolyBio Research Foundation|The Anlyan Center

Long COVID-19

2025-04-18 PHASE3
NCT00446264 University Hospital, Lille|Institut National de la Santé Et de la Recherche Médicale, France

Type 1 Diabetes|Hypoglycemia|Metabolic Diseases

2003-05 PHASE2
NCT02133287 Beijing AmsinoMed Medical Device Co., Ltd

Ischemic Heart Disease|Myocardial Ischemia|Coronary Disease|Acute Coronary Syndrome

2013-08 NA
NCT05324384 West China Hospital

Hemangioendothelioma

2022-04-05 PHASE2
NCT00346918 University of Zurich

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

2006-06 PHASE3
NCT00061568 National Heart, Lung, and Blood Institute (NHLBI)

Congenital Hemolytic Anemia|Sickle Cell Disease

2004-07-16 PHASE1|PHASE2
NCT03688191 Peking Union Medical College Hospital

Connective Tissue Diseases|Thrombocytopenia

2017-09-21 PHASE4
NCT01446484 Pirogov Russian National Research Medical University|Russian Academy of Medical Sciences

End-Stage Renal Disease|Kidney Failure

2011-10 PHASE1|PHASE2
NCT00518271 Wyeth is now a wholly owned subsidiary of Pfizer

Kidney Transplantation

2000-04 PHASE2
NCT01632605 Medical University of Vienna

ADPKD

2009-11 NA
NCT00766649 National Eye Institute (NEI)

Age-Related Macular Degeneration

2008-10 PHASE1|PHASE2
NCT00005113 Boston Children´s Hospital

End-Stage Renal Disease|Kidney Transplantation

1999-07 PHASE3
NCT01453140 Hackensack Meridian Health

Graft Versus Host Disease

2011-08 PHASE1|PHASE2
性状 固体
颜色 White to off-white

化学信息

分子量 914.17
分子式 C51H79NO13
CAS No. 53123-88-9
Smiles O(C([H])([H])[H])[C@@]1([H])[C@@]([H])(C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[C@@]([H])(C([H])([H])[H])[C@]2([H])C([H])([H])C([C@@]([H])(C([H])=C(C([H])([H])[H])[C@]([H])([C@]([H])(C([C@]([H])(C([H])([H])[H])C([H])([H])[C@]([H])(C([H])([H])[H])C([H])=C([H])C([H])=C([H])C([H])=C(C([H])([H])[H])[C@]([H])(C([H])([H])[C@]3([H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@](C(C(N4C([H])([H])C([H])([H])C([H])([H])C([H])([H])[C@@]4([H])C(=O)O2)=O)=O)(O[H])O3)OC([H])([H])[H])=O)OC([H])([H])[H])O[H])C([H])([H])[H])=O)C1([H])[H])O[H] |c:35,66,70,t:62|
别名 雷帕霉素; 西罗莫司; Sirolimus; AY-22989; NSC 226080

储存&溶解度

体内实验配方
10% DMSO+40% PEG300+ 5% Tween 80 + 45% Saline: 10.00 mg/mL (10.94 mM), Solution.
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 10.00 mg/mL (10.94 mM), Solution.
10% DMSO+90% Saline: < 10 mg/mL (10.94 mM), Lower concentrations may be soluble, but exact solubility limit is unknown.
请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。
储存方式
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMSO 中的溶解度 : 100 mg/mL (109.39 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

可选溶剂 浓度 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 1.0939 mL 5.4694 mL 10.9389 mL 27.3472 mL
5 mM 0.2188 mL 1.0939 mL 2.1878 mL 5.4694 mL
10 mM 0.1094 mL 0.5469 mL 1.0939 mL 2.7347 mL
15 mM 0.0729 mL 0.3646 mL 0.7293 mL 1.8231 mL
20 mM 0.0547 mL 0.2735 mL 0.5469 mL 1.3674 mL
25 mM 0.0438 mL 0.2188 mL 0.4376 mL 1.0939 mL
30 mM 0.0365 mL 0.1823 mL 0.3646 mL 0.9116 mL
40 mM 0.0273 mL 0.1367 mL 0.2735 mL 0.6837 mL
50 mM 0.0219 mL 0.1094 mL 0.2188 mL 0.5469 mL
60 mM 0.0182 mL 0.0912 mL 0.1823 mL 0.4558 mL
80 mM 0.0137 mL 0.0684 mL 0.1367 mL 0.3418 mL
100 mM 0.0109 mL 0.0547 mL 0.1094 mL 0.2735 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

雷帕霉素;西罗莫司 相关分类

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础